Showing results (591-600 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|April 25, 2006
In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drugEsther F A Brandon, Rolf W Sparidans, Ronald D van Ooijen, et al.Investigational New Drugs|November 2, 2006
A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patientsThomas W Flaig, Daniel L Gustafson, Lih-Jen Su, et al.Investigational New Drugs|February 1, 1991
Phase II study of pibenzimol in pancreatic cancer. A Southwest Oncology Group studyE H Kraut, T Fleming, M Segal, et al.Investigational New Drugs|October 14, 2006
Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) studyTakashi Yana, Shunichi Negoro, Minoru Takada, et al.Investigational New Drugs|November 15, 2006
A phase 1 trial of XK469: toxicity profile of a selective topoisomerase IIbeta inhibitorAmin M Alousi, Ramesh Boinpally, Richard Wiegand, et al.Investigational New Drugs|July 22, 2005
Activity of carboplatin in patients with advanced non-small cell lung cancer pre-treated with a non-platinum combinationEmilio Esteban-Gonzalez, Yolanda Fernández, Noemí Villanueva, et al.Investigational New Drugs|June 10, 2010
Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal disseminationFumiko Taguchi, Yasuo Kodera, Yasufumi Katanasaka, et al.Investigational New Drugs|May 19, 2010
Geranylgeranyl diphosphate depletion inhibits breast cancer cell migrationAmel Dudakovic, Huaxiang Tong, Raymond J HohlInvestigational New Drugs|May 18, 2010
Combined anticancer effects of sphingosine kinase inhibitors and sorafenibVladimir Beljanski, Christian Knaak, Yan Zhuang, et al.Investigational New Drugs|September 30, 2010
Functional properties of synthetic N-acyl-L-homoserine lactone analogs of quorum-sensing gram-negative bacteria on the growth of human oral squamous carcinoma cellsHongbo Chai, Masaharu Hazawa, Naoko Shirai, et al.Pageof 372